{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381981471093473280.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Lori J. Wirth"}],"foaf:familyName":[{"@value":"Wirth"}],"foaf:givenName":[{"@value":"Lori J."}]}],"career":[{"institution":{"notation":[{"@value":"Department of Medicine (L.J.W.), Massachusetts General Hospital, Boston, Massachusetts 02114;"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361981471093473280","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1210/jc.2015-3989"},{"@type":"URI","@value":"http://academic.oup.com/jcem/article-pdf/101/11/4103/20287783/jcem4103.pdf"},{"@type":"PMID","@value":"27548104"}],"notation":[{"@value":"Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1210/jc.2015-3989_Zp6UuGUHYxMbPiIDuIM1wdrSntV"},{"@type":"OPENAIRE","@value":"doi_dedup___::b0cfa1a2b0c0bb40ef30448b5b0c83df_Zp6UuGUHYxMbPiIDuIM1wdrSntV"}]}